David Ermert

8PUBLICATIONS
45CO-AUTHORS
Molecular targetsTumour immunologyMedical infection agents (incl. prions)Innate immunityPeriodontics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 17, 2026
Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Employ Distinct Modes of Action to Induce Antitumor Immunity.

|Sep 26, 2025
A "Function-First" Approach to Identify Regulatory T cell-Targeting Antibodies for Immunotherapy.

Kirstie L S Cleary, Monika Semmrich, Linda Martensson

|Sep 30, 2018
Short Leucine-Rich Proteoglycans Modulate Complement Activity and Increase Killing of the Respiratory Pathogen Moraxella catarrhalis.

Maisem Laabei, Guanghui Liu, David Ermert

|Apr 08, 2018
Human IgG Increases Virulence of Streptococcus pyogenes through Complement Evasion.

David Ermert, Antonin Weckel, Michal Magda

|Nov 01, 2017
Factor H-IgG Chimeric Proteins as a Therapeutic Approach against the Gram-Positive Bacterial Pathogen Streptococcus pyogenes.

Anna M Blom, Michal Magda, Lisa Kohl

|Feb 03, 2017
PRELP Enhances Host Innate Immunity against the Respiratory Tract Pathogen Moraxella catarrhalis.

Guanghui Liu, David Ermert, Martin E Johansson

Pageof 2

Frequent Collaborators

6 joint publications

Anna M Blom

3 joint publications

Kristian Riesbeck

2 joint publications

Guanghui Liu

2 joint publications

Birendra Singh